Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH) concluded the trading at $2.03 on Friday, January 14 with a fall of -5.58% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $2.15 and 5Y monthly beta was reading -0.11 with its price kept floating in the range of $1.94 and $2.14 on the day. Considering stock’s 52-week price range provides that RVPH hit a high price of $9.61 and saw its price falling to a low level of $2.04 during that period. Over a period of past 1-month, stock came subtracting -39.40% in its value.
With its current market valuation of $26.80 million, Reviva Pharmaceuticals Holdings Inc. is set to declare its quarterly results on Mar 21, 2022 – Mar 25, 2022. Analysts are in estimates of -$0.28 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$0.84 for 2021 with estimates of that growing to -$0.84 in next year.
In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review RVPH stock’s current outlook then short term indicators are assigning it an average of 100% Sell, while medium term indicators are categorizing the stock at an average of 100% Sell. Long term indicators are suggesting an average of 100% Sell for it.
Digging deeper we become aware of the PEG ratio of the RVPH stock which is currently positioned at 0. It further provides that stock’s current price level is -28.46% away from its 20-day simple moving average and is -39.07% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 24.60 while volatility remained at 16.51% over the past week which changes to 11.58% when measuring it over the past month. Average true range or ATR is currently at 0.31.
Having a second look at Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH) provides that stock’s average daily trading volume for 3 months was 518.51K. Number of outstanding shares of the stock stood at 18.46 million.
The percentage of outstanding shares held by the insiders is 38.54% while it is 24.30% for the institutional holders. Subtraction of -29.76% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.